<p>Development and validation of a prognostic score predicting recurrence in resected combined hepatocellular cholangiocarcinoma</p>
Meng‐Xin Tian(Sun Yat-sen University), Ying–Hong Shi(Ministry of Education of the People's Republic of China), Wei‐Feng Qu(Ministry of Education of the People's Republic of China), Jiacheng Yin(Shanghai Jiao Tong University), Wei‐Ren Liu(Chung Yuan Christian University), Jian Zhou(Shenzhen University Health Science Center), Shuang–Jian Qiu(Fudan University), Han Wang(Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital), Jia Fan(Nanjing Tech University), Lei Jin(Air Force Medical University), Jingfeng Liu(Fujian Medical University), Liuping Luo(Fujian Medical University), Yuan Fang(Guangzhou University of Chinese Medicine), Chen-Yang Tao(Fudan University), Xi‐Fei Jiang(Sun Yat-sen University), Zheng Tang(Fudan University), Yufu Zhou(Central South University), Wei Deng(Wuhan University)
Cited by 15
Related Papers
Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma
|Nature|2019|982
Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition)
|Liver Cancer|2020|828